These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7044659)

  • 1. Prostaglandin therapy for peripheral vascular disease - better than placebo?
    Wennmalm A
    Clin Physiol; 1982 Apr; 2(2):85-7. PubMed ID: 7044659
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandin E1 therapy for peripheral vascular disease is better than placebo.
    Clin Physiol; 1982 Apr; 2(2):163-5. PubMed ID: 7044658
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin E1 in severe lower limb ischaemia: a double-blind controlled trial.
    Telles GS; Campbell WB; Wood RF; Collin J; Baird RN; Morris PJ
    Br J Surg; 1984 Jul; 71(7):506-8. PubMed ID: 6375799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [On the therapeutic activity of hemaseril in treatment of ischemic arteriopathies and phlebopathies].
    Tattoni G; Bigazzi P; Gritta G
    Clin Ter; 1974 Mar; 69(3):225-39. PubMed ID: 4846656
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with prostaglandin E1 in the treatment of arteriosclerosis obliterans. A preliminary report.
    Ambrus JL; Taheri P; Killion D; Donaldson G
    J Med; 1983; 14(1):1-15. PubMed ID: 6577118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary results of prostaglandin E1 therapy in peripheral obliterating arteriopathy].
    Pilger E; Juan H
    Wien Klin Wochenschr; 1983 Apr; 95(8):263-6. PubMed ID: 6683910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandins in therapy of cardiovascular disease.
    Szczeklik A; Gryglewski RJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():345-54. PubMed ID: 3159222
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostaglandin E1 treatment of leg ulcers caused by venous or arterial incompetence.
    Beitner H; Hammar H; Olsson AG; Thyresson N
    Acta Derm Venereol; 1980; 60(5):425-30. PubMed ID: 6162314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical observations with intravenous prostaglandin E1 in peripheral vascular disease.
    Feldman SM; Alpert J; Dick LS; Brief DK; Goldenkranz R; Brener BJ; Parsonnet V
    J Med Soc N J; 1982 Dec; 79(13):985-7. PubMed ID: 6961223
    [No Abstract]   [Full Text] [Related]  

  • 10. Leg ulcer healing induced by prostaglandin E1 recorded with stereophotogrammetry.
    Eklund AE; Eriksson G; Olsson AG
    Prog Lipid Res; 1981; 20():479-84. PubMed ID: 7043482
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of clinical trials of raubasin].
    Weidinger P
    Med Welt; 1970 Mar; 10():403-8. PubMed ID: 4908367
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of prostaglandin E1 in the treatment of lower extremity ischemic ulcers secondary to peripheral vascular occlusive disease. Results of a prospective randomized, double-blind, multicenter clinical trial.
    Schuler JJ; Flanigan DP; Holcroft JW; Ursprung JJ; Mohrland JS; Pyke J
    J Vasc Surg; 1984 Jan; 1(1):160-70. PubMed ID: 6384558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dalargin in the treatment of arteriosclerosis obliterans of the lower extremities].
    Dudko VA; Fedorova NA; Didenko VA; Zoloev GK
    Sov Med; 1990; (2):90-2. PubMed ID: 2192476
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of lower extremity ischemic disease in ambulatory field practice using infusions].
    Prikryl P
    Cas Lek Cesk; 1970 Jul; 109(36):866. PubMed ID: 5456093
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experiences with the new vasotherapeutic drug Trental in dermatology].
    Herger R
    Fortschr Med; 1972 Aug; 90(24):865-72. PubMed ID: 4639351
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic antral gastritis in duodenal ulcer. Natural history and treatment with prostaglandin E1.
    Hui WM; Lam SK; Ho J; Ng MM; Lui I; Lai CL; Lok AS; Lau WY; Poon GP; Choi S
    Gastroenterology; 1986 Nov; 91(5):1095-101. PubMed ID: 3093305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.
    Mizushima Y; Shiokawa Y; Homma M; Kashiwazaki S; Ichikawa Y; Hashimoto H; Sakuma A
    J Rheumatol; 1987 Feb; 14(1):97-101. PubMed ID: 3553591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of patients with occlusive arterial diseases of the legs with prostaglandin E1].
    Dibirov MD
    Vestn Khir Im I I Grek; 1988 Jun; 140(6):137-8. PubMed ID: 3222855
    [No Abstract]   [Full Text] [Related]  

  • 19. Rioprostil: a clinical experience in gastric ulcer treatment.
    Mascio G; Guida L; Mascio MV; Maggiolo F
    Int J Clin Pharmacol Res; 1988; 8(5):341-4. PubMed ID: 3147950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, hemodynamic and metabolic effects of intraarterial infusions of prostaglandin E1 in patients with peripheral vascular disease.
    Olsson AG; Carlson LA
    Adv Prostaglandin Thromboxane Res; 1976; 1():429-32. PubMed ID: 998436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.